CATALYST PHARMACEUTICALS INC (CPRX)

US14888U1016 - Common Stock

15.94  -0.33 (-2.03%)

After market: 15.9 -0.04 (-0.25%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
140.8M
18.22%
214.2M
52.13%
398.204M
85.90%
469.58M
17.92%
EBITDA
YoY % growth
52.6M
27.05%
103M
95.82%
119.693M
16.21%
188.47M
57.46%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
52.4M
26.88%
101.8M
94.27%
86.812M
-14.72%
175.41M
102.06%
Operating Margin
37.22%47.53%21.80%37.35%
EPS
YoY % growth
0.37
-9.76%
0.74
100.00%
0.81
9.46%
1.13
39.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
0.24
-7.61%
Revenue
Q2Q % growth
101.37M
18.70%
EBITDA
Q2Q % growth
52.863M
EBIT
Q2Q % growth
32.812M
-7.83%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
0.31
40.91%
0.270.0414.69%
Q3 2023
Q2Q % growth
-0.29
-245.00%
-0.290.000.24%
Q2 2023
Q2Q % growth
0.53
165.00%
0.360.1745.96%
Q1 2023
Q2Q % growth
0.26
116.67%
0.33-0.07-20.84%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
110.568M
81.86%
108.04M2.528M2.34%
Q3 2023
Q2Q % growth
102.7M
79.55%
102.38M320K0.31%
Q2 2023
Q2Q % growth
99.6M
87.57%
93.54M6.06M6.48%
Q1 2023
Q2Q % growth
85.4M
98.14%
83.249M2.151M2.58%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.88% -9.42% -7.69% -10.66%
Revenue-5.25% -2.42% -1.83% -0.39%